Signed, Sealed, Delivered: Evolving Treatment Options for the Management of Perianal Fistula in Crohn’s Disease
Roundtable #2
Pre-Assessment

Before you view the webinar, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.

There is no fee to participate in this activity.

Question Title

* 1. Where are you in your career?

IBD Specialist

General GI/GI surgeon

Trainee/Fellow

APP

PharmD

Other (please specify)

Question Title

* 2. The addition of which of the following to an anti-TNF agent is associated with a higher rate of CPF healing vs the anti-TNF agent alone?

Ciprofloxacin

Mesalamine

Prednisone

Probiotic

Question Title

* 3. A 25-year-old male with a recent diagnosis of CD presents with extreme perianal pain. A pelvic MRI is performed, leading to a diagnosis of CPF and abscess. Drainage of abscess and An examination under anesthesia is performed, during which a seton is placed in an intersphincteric fistula. The patient asks what to expect regarding his future course of therapy.

Which of the following is an appropriate response?

About one-third of patients experience treatment-refractory CPF

Antibiotic monotherapy is associated with a high rate of CPF healing

Thiopurines monotherapy is associated with high rate of CPF healing

The majority of CPF are healed with seton alone

Question Title

* 4. A 42-year-old female with refractory CPF asks about the possibility of receiving mesenchymal stem cell (MSC) therapy on a clinical trial. What do you tell the patient is an important education point regarding MSCs?

MSCs are associated with a high risk of infection

MSCs are extracted either from a healthy, voluntary donor or the patient’s own fat tissue

MSCs are extracted several weeks before they are reinjected into the patient

MSCs are primarily obtained from the spleen

Question Title

* 5. According to the 2022 proposed new Expert Consensus (published in The Lancet Gastroenterology & Hepatology, linked here), refractory CPF despite ostomy requiring proctectomy is considered which class?

Class 1

Class 2

Class 3

Class 4

Question Title

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).
Please note that we will not forward or sell your contact information.

First and Last Name *

State/Province

ZIP/Postal Code *

Country

Email Address (required to receive credit) *

Signed, Sealed, Delivered: Evolving Treatment Options for the Management of Perianal Fistula in Crohn’s Disease Roundtable #2 ***Pre-Assessment***

Question Title

* 1. Where are you in your career?

Question Title

* 2. The addition of which of the following to an anti-TNF agent is associated with a higher rate of CPF healing vs the anti-TNF agent alone?

Question Title

Question Title

* 4. A 42-year-old female with refractory CPF asks about the possibility of receiving mesenchymal stem cell (MSC) therapy on a clinical trial. What do you tell the patient is an important education point regarding MSCs?

Question Title

* 5. According to the 2022 proposed new Expert Consensus (published in The Lancet Gastroenterology & Hepatology, linked here), refractory CPF despite ostomy requiring proctectomy is considered which class?

Question Title

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).*Please note that we will not forward or sell your contact information.*

Signed, Sealed, Delivered: Evolving Treatment Options for the Management of Perianal Fistula in Crohn’s Disease
Roundtable #2
Pre-Assessment

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).
Please note that we will not forward or sell your contact information.